Tech

Russian intelligence reportedly used fake news sites to spread misinformation about coronavirus vaccines

Four online publications linked to Russian intelligence disseminate false or misleading information about the coronavirus vaccine. The Wall Street Journal report, Quotes from a US State Department Global Engagement Center official.

Sites identified as New Eastern Outlook, Oriental Review, News Front, and Rebel Inside highlight the side effects of Pfizer’s coronavirus vaccine and other western pharmaceutical companies’ vaccines, raising concerns about whether the vaccine is effective or in a hurry. Has stated. Through the US approval process WSJ Said.

Although the site does not have a large audience, officials said their false stories were often picked up and circulated by the international media. They usually focus on true news reports on the rare side effects of vaccines, but they do not provide the exact context that vaccines are safe for most people. “Russian intelligence has a direct responsibility to spread propaganda and lies using these four platforms,” ​​a State Department spokesman said. WSJ..

In addition to campaigns that undermine the credibility of Western vaccines, Russian national media and Twitter accounts related to the Russian government are also trying to raise the profile of the Russian Sputnik V vaccine.

The Kremlin spokesperson WSJ..

Russia announced in November The Sputnik V vaccine was 90% effective, but critics said the vaccine’s clinical trials in patients were too small.But the British medical journal Lancet report Last month, a large test revealed that Sputnik V was safe and had an efficacy rate of 91%. according to Associated Press, As of late February, only 4 million people, about 3 percent of the population, were vaccinated in Russia.

Russian intelligence reportedly used fake news sites to spread misinformation about coronavirus vaccines Source link Russian intelligence reportedly used fake news sites to spread misinformation about coronavirus vaccines

Related Articles

Back to top button